What does DOKTER STAS AN, ALGEMENE GENEESKUNDE do?

DOKTER STAS AN, ALGEMENE GENEESKUNDE is a general practice in Sint-Pieters-Leeuw. Private Limited, started on 15 May 2008.

What is the address of DOKTER STAS AN, ALGEMENE GENEESKUNDE?

The registered office of DOKTER STAS AN, ALGEMENE GENEESKUNDE is located at Frederik Coevoetstraat 48, 1600 Sint-Pieters-Leeuw.

Is DOKTER STAS AN, ALGEMENE GENEESKUNDE still active?

Yes. According to the CBE (19 September 2026) DOKTER STAS AN, ALGEMENE GENEESKUNDE is active, legal situation “Normale toestand”, started on 15 May 2008.

Is DOKTER STAS AN, ALGEMENE GENEESKUNDE registered on Peppol?

Yes, DOKTER STAS AN, ALGEMENE GENEESKUNDE is registered on the Peppol network with ID 0208:0897919003.

What is the enterprise number of DOKTER STAS AN, ALGEMENE GENEESKUNDE?

The enterprise number of DOKTER STAS AN, ALGEMENE GENEESKUNDE is BE0897919003.

When was DOKTER STAS AN, ALGEMENE GENEESKUNDE founded?

DOKTER STAS AN, ALGEMENE GENEESKUNDE was founded on 15 May 2008.

Who are the directors of DOKTER STAS AN, ALGEMENE GENEESKUNDE?

According to the 2025 annual accounts, the directors of DOKTER STAS AN, ALGEMENE GENEESKUNDE are: An Elisabeth Stas.

Is DOKTER STAS AN, ALGEMENE GENEESKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 May 2008; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER STAS AN, ALGEMENE GENEESKUNDE make in 2025?

DOKTER STAS AN, ALGEMENE GENEESKUNDE posted a profit after taxes of € 86,630 in financial year 2025.

What is the revenue of DOKTER STAS AN, ALGEMENE GENEESKUNDE?

As a small company, DOKTER STAS AN, ALGEMENE GENEESKUNDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 131,919.

DOKTER STAS AN, ALGEMENE GENEESKUNDE (Private Limited)

Dossier DOKTER STAS AN, ALGEMENE GENEESKUNDE, printed on 19 September 2026 from databakkes.be/en/0897919003/dokter-stas-an-algemene-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER STAS AN, ALGEMENE GENEESKUNDE from Sint-Pieters-Leeuw, company number BE0897919003, closed financial year 2025 with a result of € 86,630 after tax. For that financial year DOKTER STAS AN, ALGEMENE GENEESKUNDE recorded a gross margin of € 131,919 and equity of € 383,433. Compared with financial year 2024, the result moved from € 79,768 to € 86,630. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 5, 2026.

What it is worth Growing

€ 383,433

▲ 28% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 86,630

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 110,181

▼ 57% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 1,666 paid out

2 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 43,050

▲ € 42,288 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 30,475

▲ € 25,379 vs 2024

€ 5,097 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 2,079

▲ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,892

▲ 50% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 92,783 Gross margin 2022: € 92,783 First fiscal year in the series	€ 101,335 Gross margin 2023: € 101,335 ▲ 9% vs 2022 (€ 92,783) Favourable step	€ 110,196 Gross margin 2024: € 110,196 ▲ 9% vs 2023 (€ 101,335) Favourable step	€ 131,919 Gross margin 2025: € 131,919 ▲ 20% vs 2024 (€ 110,196) Favourable step	▲ 20%
Profit after taxes	€ 55,175 Profit after taxes 2022: € 55,175 First fiscal year in the series	€ 72,189 Profit after taxes 2023: € 72,189 ▲ 31% vs 2022 (€ 55,175) Favourable step	€ 79,768 Profit after taxes 2024: € 79,768 ▲ 10% vs 2023 (€ 72,189) Favourable step	€ 86,630 Profit after taxes 2025: € 86,630 ▲ 9% vs 2024 (€ 79,768) Favourable step	▲ 9%
Equity	€ 192,154 Equity 2022: € 192,154 First fiscal year in the series	€ 246,307 Equity 2023: € 246,307 ▲ 28% vs 2022 (€ 192,154) Favourable step	€ 298,469 Equity 2024: € 298,469 ▲ 21% vs 2023 (€ 246,307) Favourable step	€ 383,433 Equity 2025: € 383,433 ▲ 28% vs 2024 (€ 298,469) Favourable step	▲ 28%
Total debts	€ 39,468 Total debts 2022: € 39,468 First fiscal year in the series	€ 38,222 Total debts 2023: € 38,222 ▼ 3% vs 2022 (€ 39,468) Favourable step	€ 14,264 Total debts 2024: € 14,264 ▼ 63% vs 2023 (€ 38,222) Favourable step	€ 43,112 Total debts 2025: € 43,112 ▲ 202% vs 2024 (€ 14,264) Unfavourable step	▲ 202%
Cash	€ 140,916 Cash 2022: € 140,916 First fiscal year in the series	€ 197,732 Cash 2023: € 197,732 ▲ 40% vs 2022 (€ 140,916) Favourable step	€ 258,145 Cash 2024: € 258,145 ▲ 31% vs 2023 (€ 197,732) Favourable step	€ 110,181 Cash 2025: € 110,181 ▼ 57% vs 2024 (€ 258,145) Unfavourable step	▼ 57%
Land & buildings	€ 2,205 Land & buildings 2022: € 2,205 First fiscal year in the series	-	-	€ 3,028 Land & buildings 2025: € 3,028 First fiscal year in the series
Retained profit	€ 173,554 Retained profit 2022: € 173,554 First fiscal year in the series	€ 227,707 Retained profit 2023: € 227,707 ▲ 31% vs 2022 (€ 173,554) Favourable step	€ 279,869 Retained profit 2024: € 279,869 ▲ 23% vs 2023 (€ 227,707) Favourable step	€ 364,833 Retained profit 2025: € 364,833 ▲ 30% vs 2024 (€ 279,869) Favourable step	▲ 30%
Dividend	€ 10,092 Dividend 2022: € 10,092 First fiscal year in the series	€ 18,037 Dividend 2023: € 18,037 ▲ 79% vs 2022 (€ 10,092) Unchanged	€ 27,606 Dividend 2024: € 27,606 ▲ 53% vs 2023 (€ 18,037) Unchanged	€ 1,666 Dividend 2025: € 1,666 ▼ 94% vs 2024 (€ 27,606) Unchanged	▼ 94%
Bank debt	€ 7,070 Bank debt 2022: € 7,070 First fiscal year in the series	€ 5,039 Bank debt 2023: € 5,039 ▼ 29% vs 2022 (€ 7,070) Favourable step	€ 5,096 Bank debt 2024: € 5,096 ▲ 1% vs 2023 (€ 5,039) Unfavourable step	€ 30,475 Bank debt 2025: € 30,475 ▲ € 25,379 vs 2024 (€ 5,096) Unfavourable step	▲ € 25,379
Balance sheet total	€ 231,622 Balance sheet total 2022: € 231,622 First fiscal year in the series	€ 284,529 Balance sheet total 2023: € 284,529 ▲ 23% vs 2022 (€ 231,622) Unchanged	€ 312,733 Balance sheet total 2024: € 312,733 ▲ 10% vs 2023 (€ 284,529) Unchanged	€ 426,545 Balance sheet total 2025: € 426,545 ▲ 36% vs 2024 (€ 312,733) Unchanged	▲ 36%

Key figures of DOKTER STAS AN, ALGEMENE GENEESKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DOKTER STAS AN, ALGEMENE GENEESKUNDE?

What happened at DOKTER STAS AN, ALGEMENE GENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jan 5, 2026 New annual accounts for financial year 2025: profit of € 86,630 (▲ 9% vs 2024). Source: NBB ↗
May 15, 2008 Start of the company according to the CBE. KBO

In short

From € 55,175 profit in 2022 to € 86,630 profit in 2025.

Paid € 114,586 in corporate taxes since 2022.

Best year ever: 2025, with € 86,630 profit.

Paid out € 57,400 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER STAS AN, ALGEMENE GENEESKUNDE? We notify you, reason included.

Follow DOKTER STAS AN, ALGEMENE GENEESKUNDE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

An Elisabeth Stas

DOKTER STAS AN, ALGEMENE GENEESKUNDE

Behind DOKTER STAS AN, ALGEMENE GENEESKUNDE is An Elisabeth Stas.

See the full network in the app

Directors

According to the 2025 annual accounts

An Elisabeth Stas

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Frederik Coevoetstraat 48

1600 Sint-Pieters-Leeuw

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0897.919.003
VAT number: BE 0897.919.003
Registered office: Frederik Coevoetstraat 48, 1600 Sint-Pieters-Leeuw
Names & denominations: DOKTER STAS AN, ALGEMENE GENEESKUNDE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 15 May 2008
Peppol: Active · Active since 21 Oct 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗